Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
Cook, S, Vermersch, P, Comi, G, Giovannoni, G, Rammohan, K, Rieckmann, P, Sørensen, P Soelberg, Hamlett, A, Miret, M, Weiner, J, Viglietta, V, Musch, B, Greenberg, SJ
Published in Multiple sclerosis (01.05.2011)
Published in Multiple sclerosis (01.05.2011)
Get full text
Journal Article
Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect
Voldsgaard, A, Bager, P, Garde, E, Åkeson, P, Leffers, AM, Madsen, CG, Kapel, C, Roepstorff, A, Thamsborg, SM, Melbye, M, Siebner, H, Søndergaard, HB, Sellebjerg, F, Sørensen, P Soelberg
Published in Multiple sclerosis (01.11.2015)
Published in Multiple sclerosis (01.11.2015)
Get full text
Journal Article
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
Elovaara, I., Apostolski, S., Van Doorn, P., Gilhus, N. E., Hietaharju, A., Honkaniemi, J., Van Schaik, I. N., Scolding, N., Soelberg Sørensen, P., Udd, B.
Published in European journal of neurology (01.09.2008)
Published in European journal of neurology (01.09.2008)
Get full text
Journal Article
Spinal cord atrophy in anterior‐posterior direction reflects impairment in multiple sclerosis
Lundell, H., Svolgaard, O., Dogonowski, A.‐M., Romme Christensen, J., Selleberg, F., Soelberg Sørensen, P., Blinkenberg, M., Siebner, H. R., Garde, E.
Published in Acta neurologica Scandinavica (01.10.2017)
Published in Acta neurologica Scandinavica (01.10.2017)
Get full text
Journal Article
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial
Fazekas, F, Lublin, F D, Li, D, Freedman, M S, Hartung, H P, Rieckmann, P, Sørensen, P Soelberg, Maas-Enriquez, M, Sommerauer, B, Hanna, K
Published in Neurology (22.07.2008)
Published in Neurology (22.07.2008)
Get more information
Journal Article
Identification of new sensitive biomarkers for the in vivo response to interferon-β treatment in multiple sclerosis using DNA-array evaluation
Sellebjerg, F., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch-Henriksen, N., Svejgaard, A., Soelberg Sørensen, P.
Published in European journal of neurology (01.12.2009)
Published in European journal of neurology (01.12.2009)
Get full text
Journal Article
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis
Andersen, O, Elovaara, I, Färkkilä, M, Hansen, H J, Mellgren, S I, Myhr, K-M, Sandberg-Wollheim, M, Soelberg Sørensen, P
Published in Journal of neurology, neurosurgery and psychiatry (01.05.2004)
Published in Journal of neurology, neurosurgery and psychiatry (01.05.2004)
Get full text
Journal Article
Gene expression analysis of interferon-β treatment in multiple sclerosis
Sellebjerg, F, Datta, P, Larsen, J, Rieneck, K, Alsing, I, Oturai, A, Svejgaard, A, Soelberg Sørensen, P, Ryder, LP
Published in Multiple sclerosis (01.06.2008)
Published in Multiple sclerosis (01.06.2008)
Get full text
Journal Article
Rethinking MS in Europe: Prioritizing integrated services for people with multiple sclerosis
Battaglia, M A, Pugliatti, M, Soelberg Sørensen, P, Tiu, C, Carrascal, P, Quoidbach, V
Published in European journal of public health (01.09.2020)
Published in European journal of public health (01.09.2020)
Get full text
Journal Article
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases
Elovaara, I, Apostolski, S, van Doorn, P, Gilhus, N E, Hietaharju, A, Honkaniemi, J, van Schaik, I N, Scolding, N, Soelberg Sørensen, P, Udd, B
Published in European journal of neurology (01.09.2008)
Published in European journal of neurology (01.09.2008)
Get full text
Journal Article
Conference Proceeding
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
Roxburgh, R H S R, Seaman, S R, Masterman, T, Hensiek, A E, Sawcer, S J, Vukusic, S, Achiti, I, Confavreux, C, Coustans, M, le Page, E, Edan, G, McDonnell, G V, Hawkins, S, Trojano, M, Liguori, M, Cocco, E, Marrosu, M G, Tesser, F, Leone, M A, Weber, A, Zipp, F, Miterski, B, Epplen, J T, Oturai, A, Sørensen, P Soelberg, Celius, E G, Lara, N Téllez, Montalban, X, Villoslada, P, Silva, A M, Marta, M, Leite, I, Dubois, B, Rubio, J, Butzkueven, H, Kilpatrick, T, Mycko, M P, Selmaj, K W, Rio, M E, Sá, M, Salemi, G, Savettieri, G, Hillert, J, Compston, D A S
Published in Neurology (12.04.2005)
Published in Neurology (12.04.2005)
Get more information
Journal Article
CD26+CD4+T cell counts and attack risk in interferon-treated multiple sclerosis
Sellebjerg, F, Ross, C, Koch-Henriksen, N, Sørensen, P Soelberg, Frederiksen, J L, Bendtzen, K, Sørensen, T L
Published in Multiple sclerosis (01.12.2005)
Published in Multiple sclerosis (01.12.2005)
Get full text
Journal Article
International consensus statement on the use of disease-modifying agents in multiple sclerosis
Freedman, M S, Blumhardt, L D, Brochet, B, Comi, G, Noseworthy, J H, Sandberg-Wollheim, M, Sørensen, P Soelberg
Published in Multiple sclerosis (01.02.2002)
Published in Multiple sclerosis (01.02.2002)
Get full text
Journal Article